3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Glioblastoma
2
Stroke
1
Recurrence
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Inflammatory Breast Neoplasms
1
Fallopian Tube Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Advanced Malignant Solid Neoplasm
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
Biopsy
2
trastuzumab biosimilar HLX02
1
pembrolizumab
1
Watchful Waiting
1
Transcutaneous Electric Nerve Stimulation
1
Standard of Care
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
Practice Guidelines as Topic
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Observation
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Palliative Care
×
30 days
×
Clear all
No trials found.